Standard BioTools Inc. Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions
Standard BioTools Inc. (LAB) reported Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions of $138.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions · last filed 2025-03-11
- Standard BioTools Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2023 was $138.00K.
- Standard BioTools Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2023-12-31 | $138.00K 10-K · filed 2025-03-11 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |